Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
2.080
+0.430 (26.06%)
At close: Apr 17, 2025, 4:00 PM
2.090
+0.010 (0.48%)
After-hours: Apr 17, 2025, 7:58 PM EDT
Agenus Employees
Agenus had 316 employees as of December 31, 2024. The number of employees decreased by 73 or -18.77% compared to the previous year.
Employees
316
Change (1Y)
-73
Growth (1Y)
-18.77%
Revenue / Employee
$327,415
Profits / Employee
-$719,706
Market Cap
52.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
AGEN News
- 24 days ago - Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025 - Business Wire
- 4 weeks ago - Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation - Business Wire
- 5 weeks ago - Agenus Inc. (AGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program - Business Wire
- 7 weeks ago - Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications - Business Wire
- 7 weeks ago - Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference - Business Wire
- 7 weeks ago - Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report - Business Wire
- 7 weeks ago - Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting - Business Wire